Investment
Invested EUR 6M from Vesalius Biocapital IV in ENYO Pharma's Series C.
ENYO Pharma
JUN 12, 2025
Every public signal F4 has attached to this firm, with sources and cross-entity links.
ENYO Pharma
Vesalius Biocapital IV first close
Vesalius Biocapital III final close